GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

2  3  4  5    7    9  10  11  
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity
9/30/2012 | published by: GBI Research
... - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity”. The report examines the reasons why the pharmaceutical industry is looking for improvements in efficiency whilst acknowledging that pharmaceutical R&D remains a long and ...  |  read more...
USD 3,500
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy
9/30/2012 | published by: GBI Research
... - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy”. This report examines the roles of Key Opinion Leaders (KOLs) within the pharmaceutical industry now and in the future. It looks at the ...  |  read more...
USD 3,500
Surgical Equipment Market to 2018 - Increased Access to Ambulatory Surgical Centers to Drive Outpatient Surgery Volumes
9/11/2012 | published by: GBI Research
... Outpatient Surgery Volumes” provides key data, information and analysis on the global surgical equipment market. The report provides market landscape, competitive landscape and market trends information on the three surgical equipment market categories: surgical sutures, ...  |  read more...
USD 3,500
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
9/11/2012 | published by: GBI Research
... Development Costs and Time to Market”, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has studied various hurdles at different stages of drug development that ...  |  read more...
USD 3,500
Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
9/11/2012 | published by: GBI Research
... Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance”. The report provides an overview of the most exciting innovations in drug delivery technologies in major therapeutic areas – oncology, vaccines, diabetes, rheumatology ...  |  read more...
USD 3,500
Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management
8/31/2012 | published by: GBI Research
... Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management”, provides key data, information and analysis on the global diabetes care devices market. The report provides the market landscape, competitive ...  |  read more...
USD 3,500
Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
8/22/2012 | published by: GBI Research
... Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region provides detailed insight into the Americas API market. The research presents detailed ...  |  read more...
USD 3,500
Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management
8/22/2012 | published by: GBI Research
... “Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management”, which provides insights into the key applications of cloud computing in the ...  |  read more...
USD 3,500
Substance Abuse Therapeutics Market to 2018 - Effective Drug Therapies in the Treatment of Alcohol and Opioid Dependence Offer Significant Market Opportunities
8/22/2012 | published by: GBI Research
... entitled “Substance Abuse Therapeutics Market to 2018 - Effective Drug Therapies in the Treatment of Alcohol and Opioid Dependence Offer Significant Market Opportunities”. The report provides insights into the substance abuse therapeutics market including market ...  |  read more...
USD 3,500
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
8/22/2012 | published by: GBI Research
... - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management”. The report focuses on the current scenario of clinical supply chain management. Key segments of the clinical supply chain which are covered ...  |  read more...
USD 3,500
Retail Clinics - 2012 Yearbook
8/6/2012 | published by: GBI Research
... restraints. The report provides market forecasts for the retail clinic industry until 2018 and the distribution of the retail clinics across the US. The key stakeholders and their issues are also addressed. The report provides ...  |  read more...
USD 3,500
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
8/6/2012 | published by: GBI Research
... Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical ...  |  read more...
USD 3,500
Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth
7/31/2012 | published by: GBI Research
... Conventional Hydraulic Models to Drive Market Growth” provides key data, information and analysis on the global hospital supplies market. The report provides a market landscape, competitive landscape and market trends information on the six hospital ...  |  read more...
USD 3,500
Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
7/31/2012 | published by: GBI Research
... Procedures and Reimbursement for New Indications to Increase Uptake” provides key data, information and analysis on the global endoscopy devices market. The report provides a market landscape, competitive landscape and market trends information on the ...  |  read more...
USD 3,500
Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
7/31/2012 | published by: GBI Research
... with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth”, provides key data, information and analysis on the global neurostimulation devices market. The report provides the market landscape, competitive landscape and market trend information on five ...  |  read more...
USD 3,500
Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
7/31/2012 | published by: GBI Research
... latest research report, entitled “Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency”. The report provides key data, information ...  |  read more...
USD 3,500
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies
7/31/2012 | published by: GBI Research
... released its latest research, “e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies”, which provides key data and ...  |  read more...
USD 3,500
Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
7/31/2012 | published by: GBI Research
... Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets”. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house ...  |  read more...
USD 3,500
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
7/10/2012 | published by: GBI Research
... Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity” provides detailed insight into the Europe API market. ...  |  read more...
USD 3,500
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7/10/2012 | published by: GBI Research
... “Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities”. It provides a comprehensive overview of the healthcare system, and the pricing and reimbursement ...  |  read more...
USD 3,500
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
7/10/2012 | published by: GBI Research
... Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline” which provides insights into the global oncology pipeline. The report is built using data and information sourced from proprietary databases, primary and secondary ...  |  read more...
USD 3,500
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
7/10/2012 | published by: GBI Research
... Development. Over the last decade, protein and peptide-based therapeutics have attracted more and more attention in the pharmaceutical industry. These types of molecules exert a high level of specificity on their respective molecular targets, making ...  |  read more...
USD 3,500
Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
7/10/2012 | published by: GBI Research
... of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise”, which provides an overview of the discovery and development of therapeutic drug combinations and multi-target drugs for oncology. The report is built using ...  |  read more...
USD 3,500
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing
7/10/2012 | published by: GBI Research
... Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical supply chain ...  |  read more...
USD 3,500
Biobanks - 2012 Year Book
7/10/2012 | published by: GBI Research
... major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. It also provides comprehensive analysis of funding, harmonization, the cost ...  |  read more...
USD 3,500
2  3  4  5    7    9  10  11  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!